POLYVIHNCT07388394
Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved 3 months later.
See at-risk trials from Centre Hospitalier Universitaire de Nice
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Recruitment resumed after suspension Show 4 more changesShow less
- Eligibility criteria expanded, about 7 words
- Primary and study completion pushed from May 31, 2027 to Aug 31, 2027
- Secondary endpoints: details revised at 3 of 3 entries
- Site details revised
- Stopped Recruitment suspended Sponsor's reason: The inclusions have been suspended pending approval of an amendment to the protocol
- Site details revised
- Notable Recruitment opened
- Start date changed from estimate of Feb 15, 2026 to Jan 28, 2026
- Site details revised
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
Endpoints
Primary
Describe polypharmacy among people living with HIV aged 75 and older.
Timeframe: 18 months
Secondary (3)
Assess the most common comorbidities associated with polypharmacy in the population of PLHIV aged 75
Assess whether people taking multiple medications have a lower treatment adherence score than those taking fewer medications.
Assess the level of functional independence in this age group and link it to the existence of polypharmacy.
Arms and interventions
people living with HIV over the age of 75Other
Other: interview with advanced practice nurse
Sites
1 site in 1 country
- CHU de NICENice, CHU de Nice, France